MMM

3MA

NYSE / Capital Goods

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment CodexPost-earnings T+3

B+

Bull case

30%

Probability

Target price

$218.00

Analysis reference price unavailable

Analysis 2026-07-24 · RankAlpha Sentiment Codex

Most likely

Base case

50%

Probability

Target price

$185.00

Analysis reference price unavailable

Analysis 2026-07-24 · RankAlpha Sentiment Codex

B-

Bear case

20%

Probability

Target price

$150.00

Analysis reference price unavailable

Analysis 2026-07-24 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-07-24

AI commentary

News tone is strongly positive after the earnings beat, guidance increase, and subsequent analyst target hikes. Market coverage reported MMM rising as much as 10.7% on July 21; it then closed at $170.76 on July 22 and $169.59 on July 23, indicating some digestion below the initial high. Analyst reaction is constructive through the Goldman Sachs and UBS target increases, but broader consensus-revision breadth remains unavailable. Social, options, short-interest, and employee-sentiment data are unavailable.

RankAlpha Sentiment Codex - 2026-07-24

Open post-earnings memo

Evidence flagged

later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence

Impact

tentative

Confidence

AI events

2026-07-21eventQ2 beat and raised FY2026 guidanceMedium impact

3M reported Q2 adjusted sales of $6.5 billion, 5.4% adjusted organic growth, 24.9% adjusted operating margin, and adjusted EPS of $2.40. FY2026 adjusted EPS guidance increased to $8.80-$8.95 from $8.50-$8.70, with higher sales, margin, and cash-flow targets. [#SEC-8K-2026-07-21]

2026-07-22catalystPost-print analyst target revisionsMedium impact

Goldman Sachs raised its target to $202 from $190 and maintained Buy, citing Q2 segment EBIT approximately 3% above consensus and 5.4% organic growth. UBS raised its target to $218 from $190 and maintained Buy, citing accelerating growth. Revision breadth is constructive, but the RankAlpha analyst-count field remains unavailable.

2026-12-31catalystMargin and cash-conversion executionHigh impact

Management targets 70-80 bps of adjusted operating-margin expansion, $5.8-$6.0 billion of adjusted operating cash flow, and greater than 100% adjusted free-cash-flow conversion for 2026. Sustained productivity gains and commercial execution are the longer-term validation points. [#SEC-8K-2026-07-21]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-07-24 • Updated nightlySource: Internal modelMethodology